bpc 157 dr berg BPC-157 – Mark Hyman, MD Daniel J. Berg | University

BPC-157 maintained its effect even under nitric oxide synthase blockade, supporting its modulation of central dopaminergic and serotonergic signaling

Some people may notice positive changes in their appetite, such as reduced cravings or feeling more satisfied between meals, within a few weeks, but the most significant results are likely to happen when you reach the maintenance dose from around week 13 of treatment

This dose has been extensively studied in combination with semaglutide under the investigational name CagriSema, achieving up to 22.7% weight reduction at 68 weeks in phase 3 trials [4]

However, since the fragment lacks methionine, this consideration becomes irrelevant